SCHEMBL241045

SCHEMBL241045

C1CC2C[N]CC12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9046191 0.84
SCHEMBL240836 0.84
SCHEMBL9048889 0.84
SCHEMBL9049423 0.84
SCHEMBL9821115 0.81 ALDH1A1 (0.47)
SCHEMBL8062482 0.75 GABRA1 (0.32)
SCHEMBL7845053 0.73
SCHEMBL65274 0.73
SCHEMBL1224717 0.73
SCHEMBL677195 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 353 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023247590-A1 TRIAZOLOPYRIDINE AND BENZOISOXAZOLE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS ACTELION PHARMACEUTICALS LTD (CH) 2023-12-28 WO claimed
US-10695334-B2 Heteroaromatic carboxamide derivatives as plasma kallikrein inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2020-06-30 US claimed
US-20200054617-A1 Heteroaromatic Carboxamide Derivatives as Plasma Kallikrein Inhibitors BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2020-02-20 US claimed
US-10053434-B2 Histone deacetylase inhibitors and compositions and methods of use thereof CHDI FOUNDATION, INC. (US) 2018-08-21 US claimed
EP-3303326-A1 HETEROCYCLIC ESTROGEN RECEPTOR MODULATORS AND USES THEREOF H. Hoffnabb-La Roche Ag (CH) 2018-04-11 EP claimed
EP-3291810-A1 HISTONE DEACETYLASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF CHDI Foundation, Inc. (US) 2018-03-14 EP claimed
EP-2852584-B1 SUBSTITUTED DIPYRIDYLAMINES AND USES THEREOF HOFFMANN LA ROCHE (CH) 2018-02-28 EP claimed
EP-3205648-A1 ESTROGEN RECEPTOR MODULATORS AND USES THEREOF Seragon Pharmaceuticals, Inc. (US) 2017-08-16 EP claimed
WO-2016189011-A1 HETEROCYCLIC ESTROGEN RECEPTOR MODULATORS AND USES THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2016-12-01 WO claimed
US-20160347742-A1 HETEROCYCLIC ESTROGEN RECEPTOR MODULATORS AND USES THEREOF GENENTECH, INC. (US) 2016-12-01 US claimed
EP-0260555-A1 Benzo-fused cycloalkane and oxa- and thia-, cycloalkane trans-1,2-diamine derivatives THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1988-03-23 EP claimed
EP-0224566-A1 ANTIARRHYTHMIC USE FOR AMINOCYCLOALKYLAMIDES THE UPJOHN COMPANY (US) 1987-06-10 EP claimed
US-4632935-A Omega-(hydroxy-, ether and ester)-alkyl-2-amino-cycloalkyl- and cycloalkenyl amides as analgesics THE UPJOHN COMPANY (US) 1986-12-30 US claimed
WO-1986007257-A2 ANTIARRHYTHMIC USE FOR AMINOCYCLOALKYLAMIDES THE UPJOHN COMPANY (US) 1986-12-18 WO claimed
EP-0176309-A2 Use of N-(2-aminocyclohexyl)benzeneacetamides in the treatment of cerebral ischemia THE UPJOHN COMPANY (US) 1986-04-02 EP claimed
EP-0167253-A1 Hydroxyalkylcycloalkylbenzeneacetamides and benzamides THE UPJOHN COMPANY (US) 1986-01-08 EP claimed
US-4508911-A Amine intermediates for analgesic compounds THE UPJOHN COMPANY (US) 1985-04-02 US claimed
EP-0129991-A1 2-Aminocycloalkenyl carboxamides and their tritiated 2-aminocycloalkyl carboxamide derivatives THE UPJOHN COMPANY (US) 1985-01-02 EP claimed
US-4463013-A Oxygen substituted amino-cyclohexyl-benzeneacetamides and -benzamides as water diuretic drugs THE UPJOHN COMPANY (US) 1984-07-31 US claimed
US-4438130-A Analgesic 1-oxa-, aza- and thia-spirocyclic compounds THE UPJOHN COMPANY (US) 1984-03-20 US claimed